Trial intelligence / Profile preview

BOTOX versus placebo plus standard care for adult post-stroke focal spasticity

2007-000735-26Phase 3Completed

Sponsor
Allergan
Start
Apr 2007
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in poststroke spasticity (PSS) and Muscle spasm comparing BOTOX + standard of care with Placebo + standard of care (2 arms). Primary endpoint: Achievement of principal active functioning goal. Started Apr 2007; status: completed.

02

Drugs

botulinum toxin type A
03

Conditions

poststroke spasticity (PSS)Muscle spasm

Beyond the preview

Go deeper on 2007-000735-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-000735-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call